Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/24242
Title: | Investigating the Effect of Phage Therapy on the Gut Microbiome of Gnotobiotic ASF Mice |
Authors: | Ganeshan, Sharita |
Advisor: | Hosseini-Doust, Zeinab |
Department: | Biomedical Engineering |
Keywords: | bacteriophage;phage therapy;ASF;gnotobiotic;in vivo;mice;antibiotic resistance;co evolution;lytic phage;germ free mice;drug resistance;microbiome;microbiota;T7 phage;bacteria;bacterial infections;E.coli;e.coli infection;JM83 K12 E.coli |
Publication Date: | 2019 |
Abstract: | Mounting concerns about drug-resistant pathogenic bacteria have rekindled the interest in bacteriophages (bacterial viruses). As bacteria’s natural predators, bacteriophages offer a critical advantage over antibiotics, namely that they can be highly specific. This means that phage therapeutics can be designed to destroy only the infectious agent(s), without causing any harm to our microbiota. However, the potential secondary effects on the balance of microbiota through bacteriophage-induced genome evolution remains as one of the critical apprehensions regarding phage therapy. There exists a significant gap in knowledge regarding the direct and indirect effect of phage therapeutics on the microbiota. The aim of this thesis was to: (1) establish an in vivo model for investigation of the evolutionary dynamics and co-evolution of therapeutic phage and its corresponding host bacterium in the gut; (2) determine if phage therapy can affect the composition of the gut microbiota, (3) observe the differences of phage-resistant bacteria mutants evolved in vivo in comparison to those evolved in vitro. We used germ-free mice colonized with a consortium of eight known bacteria, known as the altered Schaedler flora (ASF). The colonizing strain of choice (mock infection) was a non-pathogenic strain E. coli K-12 (JM83) known to co-colonize the ASF model, which was challenged in vivo with T7 phage (strictly lytic). We compared the composition of the gut microbiota with that of mice not subject to phage therapy. Furthermore, the resistant mutants evolved in vivo and in vitro were characterized in terms of growth fitness and motility. |
URI: | http://hdl.handle.net/11375/24242 |
Appears in Collections: | Open Access Dissertations and Theses |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Ganeshan_Sharita_D_2018 December_MASc.pdf | 3.33 MB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.